Immatics N.V.

NASDAQ: IMTX
Share price (12/20/24): $6.85
Market cap (12/20/24): $706 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020 – amended

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Prospectus for primary offering

Prospectus for primary offering

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

T. Rowe Price Investment Management, Inc.

Rtw Investments, LP

Wellington Management Group Llp

Perceptive Advisors LLC

Perceptive Advisors LLC

News Filter

Information Contained in This Report on Form 6-K

Preliminary Note

Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME

Announces Proposed $150 Million Public Offering

Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC